Park Medi World is a doctor-led hospital chain that has stitched together North India’s largest affordable private network by doing something counter-intuitive - chasing government-insured patients that most rivals avoid, and building a collection machine efficient enough to make that pay. Founded by Dr. Ajit Gupta with a single 200-bed hospital in New Delhi in 2005, the company has since built 6 greenfield hospitals and acquired 10 more, becoming the largest private chain in Haryana and the second-largest in North India. The recurring approach is a cluster-based roll-up: buy or build mid-sized hospitals within 50 kilometres of an existing one, plug them into a shared operational backbone, and use the cash those clusters generate to fund the next acquisition or greenfield - a compounding engine that has scaled to 16 hospitals and nearly 4,000 beds without relying heavily on outside capital.
Business segments
A single integrated hospital network - one reportable segment, one operating model, one patient funnel - scaled across 14 cities through a cluster strategy that turns individual hospitals into nodes on a shared clinical and operational backbone.
1. Multi-specialty hospital services: affordable tertiary care, paid for by the government
The network fills its beds with patients covered by government schemes and self-pay middle-income families, then runs a tight receivables engine that converts slow government payments into predictable cash flow.
- Government schemes are the demand anchor - the company is empanelled under ESIC, CGHS, ECHS and Ayushman Bharat, which together provide a steady stream of patients whose bills are ultimately paid by the Central Government; 92% of receivables sit with the government, and the company uploads bills within seven days for clearance within three months.
- In-patient care drives nearly everything - surgeries, ICU treatments and complex procedures generated 95.6% of patient revenue in FY’26, with the network treating roughly 95,500 in-patients and close to 7.8 lakh out-patients across the year.
- A collection machine, not just a care provider - government payments come with a built-in gestation period, so the company has designed its entire back-end to handle that lag: debtor days ran at 129 days in FY’26, and the operational model generates enough internal cash to fund technology upgrades and expansion while waiting.
- 30 specialties under one roof - the network covers cardiology, neurology, oncology, orthopaedics, gastroenterology, organ transplants, gene therapy and more, with internal medicine alone contributing 29.5% of specialty revenue.
- Robotic surgery at scale - the group performed over 150 robotic kidney transplants, roughly 4,700 high-end angioplasties, about 1,200 cardiovascular procedures and approximately 2,600 robot-assisted knee and hip replacements during FY’26, using equipment that includes Da Vinci Robots and the indigenously developed SSI Mantra Robot across three hospitals.
2. Hospital network operations: the cluster flywheel
Every new hospital is placed within 50 kilometres of an existing one, so doctors, equipment and second-line managers can be shared - and each cluster becomes denser and cheaper to run as it grows.
- Clusters, not flagships - the company deliberately builds regional density rather than scattering hospitals across thin geographies, which creates economies of scale in procurement, doctor sharing and patient referrals.
- Managers are grown inside the system - second-line management is trained in current hospitals for three to six months before being deployed to a new facility, so the operating playbook replicates with minimal friction.
- Bought and built in equal measure - of the 16 hospitals, 6 were developed greenfield and 10 were acquired, including purchases under the Insolvency and Bankruptcy Code; acquired hospitals now contribute 70% of beds and 61% of revenue, with an average acquisition cost of ₹3.4 million per bed.
- In-house construction keeps expansion fast and cheap - the company runs its own construction unit for renovations and new projects, and allocates 70% of beds in less space than typical hospital designs require, which lowers the capital needed for each new bed.
- O&M contracts as a capital-light lever - for some expansions, the group uses Operations and Maintenance contracts rather than outright ownership, trading lower upfront investment for a faster ramp-up.
3. Pharmacy and ancillary services: the tail that follows the patient
Every hospital visit creates a downstream purchase - medicines, diagnostics, consumables - and the network captures that spend inside its own ecosystem.
- Ancillary revenue rides on patient footfall - pharmacy and ancillary services form the third revenue stream alongside in-patient and out-patient services, turning the roughly 8.7 lakh patients served annually into a captive retail base.
- A step-down subsidiary built for distribution - in May 2026, the group incorporated Healplus Medical Services Private Limited as a step-down subsidiary to undertake healthcare and ancillary services, extending the pharmacy logic beyond the hospital gates.
Group structure and partners
A parent company with a growing family of wholly owned and majority-owned subsidiaries - each acquisition typically lands in its own legal entity, preserving asset-level clarity while the centre runs the operating playbook.
- Promoter-held and tightly controlled - the founding Gupta family holds approximately 82.9% of the listed parent, Park Medi World Limited, which trades on BSE and NSE under the symbol PARKHOSPS.
- Minority partners in some entities - the consolidated balance sheet carries non-controlling interests of ₹823 million, indicating that not every subsidiary is fully owned.
- A small non-core divestment - in June 2026, a wholly owned subsidiary sold its 55% stake in Devina Derma Private Limited for a nominal sum, exiting a dermatology venture that was not material to the hospital network.